During the last session, iBio Inc (NASDAQ:IBIO)’s traded shares were 0.62 million, with the beta value of the company hitting 0.98. At the end of the trading day, the stock’s price was $4.12, reflecting an intraday loss of -6.58% or -$0.29. The 52-week high for the IBIO share is $6.89, that puts it down -67.23 from that peak though still a striking 63.59% gain since the share price plummeted to a 52-week low of $1.50. The company’s market capitalization is $40.69M, and the average intraday trading volume over the past 10 days was 0.45 million shares, and the average trade volume was 493.67K shares over the past three months.
iBio Inc (IBIO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IBIO has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
iBio Inc (NASDAQ:IBIO) trade information
iBio Inc (IBIO) registered a -6.58% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.58% in intraday trading to $4.12, hitting a weekly high. The stock’s 5-day price performance is -11.02%, and it has moved by -18.42% in 30 days. Based on these gigs, the overall price performance for the year is 258.26%. The short interest in iBio Inc (NASDAQ:IBIO) is 0.85 million shares and it means that shorts have 0.9 day(s) to cover.
The consensus price target of analysts on Wall Street is $3.6, which implies a decrease of -14.44% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.6 and $3.6 respectively. As a result, IBIO is trading at a premium of 12.62% off the target high and 12.62% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 57.55%. While earnings are projected to return 60.55% in 2025, the next five years will return 45.01% per annum.
IBIO Dividends
iBio Inc is due to release its next quarterly earnings on 2025-Feb-09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
iBio Inc (NASDAQ:IBIO)’s Major holders
iBio Inc insiders own 7.21% of total outstanding shares while institutional holders control 26.65%, with the float percentage being 28.72%.
Also, the Mutual Funds coming in first place with the largest holdings of iBio Inc (IBIO) shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund owns about 73.14 shares. This amounts to just over 0.74 percent of the company’s overall shares, with a $0.3 million market value. The same data shows that the other fund manager holds slightly less at 46.08, or about 0.47% of the stock, which is worth about $0.19 million.
